Stock Alert: Revance Therapeutics Gains 8%

Revance Therapeutics, Inc. (RVNC) shares are rising more than 8 percent on Tuesday morning. There is no company-specific announcement today so far, that could have influenced the stock action.

Currently shares are at $31.75, up 8.14 percent from its previous close of $29.36. The shares have traded in a range of $11.62-$32.20 on average volume of 516,360 for the last 52-weeks.

Earlier on August 25, the biotechnology company focused on innovative aesthetic and therapeutic offerings had announced that it will start introducing its aesthetics portfolio, including the RHA Collection of dermal fillers, resilient hyaluronic acid, and the HintMD financial technology platform in U.S. soon.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Follow RTT